Long GV, Atkinson V, Lo S, et al. Randomized phase 2 study of nivolumab (nivo) or nivo+ipilimumab (ipi) in patients (pts) with melanoma brain metastases (mets): Anti-PD1 Brain Collaboration (ABC). SMR 2017, abstract SMR09-4.
Hernieuwde blootstelling aan BRAF/MEK-remmers bij gevorderd melanoom
feb 2024 | Dermato-oncologie